Universidad: Salamanca

Grupo de investigación: NEUROBIOQUÍMICA

Correo: andrea.av@usal.es

Doutora pola Universidad de Salamanca coa tese Translational steps towards the clinical application of tat-cx43266-283 for the treatment of glioblastoma egfr as a predictor and mediator of treatment response, and positive results in combination with tumor resection in a preclinical model 2024. Dirixida por Dra. María Aránzazu Tabernero Urbieta.